Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Baitai Bioengineering is a biotechnology company based in Anji, Zhejiang, China, specializing in the development and manufacture of bioactive peptides and high-purity sodium alginate. Established as a joint venture involving Newsummit Biopharma, the company provides essential ingredients and research tools for the pharmaceutical, cosmetic, and biomedical industries. Its product portfolio includes specialized peptides for skin barrier restoration and wound healing, as well as the preS1 peptide used in Hepatitis B virus (HBV) research. Zhejiang Baitai is also a significant global supplier of sodium alginate, which is utilized in advanced drug delivery systems and wound care applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Baitai Bioengineering.